Consistently, we found that genetic mutation of POLB (reduced enzymatic activity) reduced the liver tumorigenesis, and in vitro studies further confirmed the anti-tumor properties of POLB dysfunction (Fig. 3 and Fig. S3). This evidence concerns the gene POLB and neoplasm.